208 related articles for article (PubMed ID: 16855355)
1. Cancer and venous thromboembolism. Clinical implications of strong association.
Prandoni P
Pathophysiol Haemost Thromb; 2006; 35(1-2):111-5. PubMed ID: 16855355
[TBL] [Abstract][Full Text] [Related]
2. Cancer and venous thromboembolism.
Prandoni P; Falanga A; Piccioli A
Lancet Oncol; 2005 Jun; 6(6):401-10. PubMed ID: 15925818
[TBL] [Abstract][Full Text] [Related]
3. Venous thromboembolism and cancer: prevention and therapy.
Lee AY
Vnitr Lek; 2006 Mar; 52 Suppl 1():127-8, 130-1. PubMed ID: 16637461
[TBL] [Abstract][Full Text] [Related]
4. The role of low-molecular-weight heparins as supportive care therapy in cancer-associated thrombosis.
Cunningham RS
Semin Oncol; 2006 Apr; 33(2 Suppl 4):S17-25; quiz S41-2. PubMed ID: 16638457
[TBL] [Abstract][Full Text] [Related]
5. [Heparin and cancer].
Lykke J
Ugeskr Laeger; 2006 Dec; 168(50):4397-401. PubMed ID: 17217864
[TBL] [Abstract][Full Text] [Related]
6. Venous thromboembolic disease and cancer.
Fennerty A
Postgrad Med J; 2006 Oct; 82(972):642-8. PubMed ID: 17068274
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of venous thrombosis in cancer patients: practical aspects].
Laza-Achille M; Desruennes E; Di Palma M
Bull Cancer; 2006 Mar; 93(3):271-81. PubMed ID: 16567314
[TBL] [Abstract][Full Text] [Related]
8. The role of low-molecular-weight heparins in the prevention and treatment of venous thromboembolism in cancer patients.
Lee AY
Curr Opin Pulm Med; 2003 Sep; 9(5):351-5. PubMed ID: 12904702
[TBL] [Abstract][Full Text] [Related]
9. [Venous thromboembolism and cancer].
Pavic M; Debourdeau P; Aletti M; Farge-Bancel D; Rousset H
Rev Med Interne; 2006 Apr; 27(4):313-22. PubMed ID: 16414153
[TBL] [Abstract][Full Text] [Related]
10. [Cancer and venous thromboembolism].
Meyer G; Belmont L
Rev Mal Respir; 2011 Apr; 28(4):443-52. PubMed ID: 21549900
[TBL] [Abstract][Full Text] [Related]
11. Management of thrombosis in cancer: primary prevention and secondary prophylaxis.
Lee AY
Br J Haematol; 2005 Feb; 128(3):291-302. PubMed ID: 15667530
[TBL] [Abstract][Full Text] [Related]
12. Low-molecular-weight heparins in the treatment of cancer-associated thrombosis: a new standard of care?
Burris HA
Semin Oncol; 2006 Apr; 33(2 Suppl 4):S3-16; quiz S41-2. PubMed ID: 16638456
[TBL] [Abstract][Full Text] [Related]
13. Thrombosis as a harbinger of cancer.
Prandoni P; Piccioli A
Curr Opin Hematol; 2006 Sep; 13(5):362-5. PubMed ID: 16888442
[TBL] [Abstract][Full Text] [Related]
14. Managing cancer patients with acute venous thromboembolism: exploring safe alternatives to hospitalisation.
Siragusa S; Anastasio R; Giarratano A; Malato A; Bonifacio G; Arcara C; Gebbia N
Exp Oncol; 2004 Sep; 26(3):192-5. PubMed ID: 15494686
[TBL] [Abstract][Full Text] [Related]
15. Prevention of venous thromboembolism in cancer patients.
Kakkar AK; Williamson RC
Semin Thromb Hemost; 1999; 25(2):239-43. PubMed ID: 10357091
[TBL] [Abstract][Full Text] [Related]
16. Low-molecular-weight heparin in cancer-associated thrombosis: treatment, secondary prevention, and survival.
Nishioka J; Goodin S
J Oncol Pharm Pract; 2007 Jun; 13(2):85-97. PubMed ID: 17873108
[TBL] [Abstract][Full Text] [Related]
17. Prophylaxis and treatment of venous thromboembolism in patients with cancer.
Ageno W; Squizzato A
Intern Emerg Med; 2006; 1(4):260-2. PubMed ID: 17217144
[No Abstract] [Full Text] [Related]
18. Cancer and venous thromboembolism: a multidisciplinary approach.
Sørensen HT; Johnsen SP; Nørgård B; Zacharski LR; Baron JA
Clin Lab; 2003; 49(11-12):615-23. PubMed ID: 14651332
[TBL] [Abstract][Full Text] [Related]
19. Venous thromboembolism in cancer patients: expanding horizons.
Bergqvist D
Semin Thromb Hemost; 2002 Aug; 28 Suppl 3():19-23. PubMed ID: 12232819
[TBL] [Abstract][Full Text] [Related]
20. Low-molecular-weight heparin in oncology.
Zacharski LR; Loynes JT
Anticancer Res; 2003; 23(3C):2789-93. PubMed ID: 12926114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
